Osteopal® V
Bone Cement. 510(k) K241674, from Heraeus Medical GmbH (Wehrheim, DE). Product code LOD, class 2.
As of Nov 19, 2026, K241674 is an FDA 510(k) held by Heraeus Medical GmbH, substantially equivalent on Dec 5, 2024 after 177 days, with no recalls tied to it in FDA's recall database.
- Review time: 177 days
- Recalls: 0
OSTEOPAL® V bone cement is indicated for the treatment of pathological fractures of the vertebral body due to osteoporosis, cancer, or benign lesions using a vertebroplasty or balloon kyphoplasty procedure.
- Osteopal VK050085 · Heraeus Kulzer,GmbH · Sep 14, 2005
- Refobacin Bone Cement R (110034355)K254107 · Biomet France · Apr 15, 2026
- SPECTRUM GV Bone CementK250760 · Osteoremedies, LLC · Apr 2, 2025
- SPECTRUM® GV Bone CementK231556 · Osteoremedies, LLC · Dec 20, 2023
- Bone Cement Genta, Bone Cement HV, Bone Cement LVK211163 · Tecres S.P.A. · Jan 9, 2023
- Bone Cement-Normal ViscosityK212729 · Biomecanica Industria E Comerciode Produtos Ortopedicos Ltda · May 31, 2022
- OGM 1 Polymethylmethacrylate (PMMA) bone cement, OGM 1A Polymethylmethacrylate (PMMA) bone cementK211869 · Ormed Grup Medikal Turizm Saglik Hizmetleri Sanayi VE · May 19, 2022
- PALACOS MV proK213812 · Heraeus Medical GmbH · Feb 2, 2022
- PALACOS R pro, PALACOS R+G pro, PALACOS MV+G proK210607 · Heraeus Medical GmbH · Jul 9, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 11, 2024
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3027
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files